论文信息 - Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial. - 字舞流文

Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial.

G. Bodoky | D. Cunningham | Chung-Pin Li | Li‐Tzong Chen | F. Braiteh | J. Blanc | R. Hubner | J. Siveke | G. Schwartsmann | T. Macarulla | C. Chiu | Y. Shan | Kyung-Hun Lee | A. Wang-Gillam | A. Dean | G. Jameson | B. Belanger | F. D. de Jong | K. Mamlouk